Checked.be
Active
BE 0829.840.938Private limited company (pre-2019)Open bankruptcy
NEUROGENE-RIBAI
Louis Ernottestraat 58B ·1170 Watermaal-Bosvoorde, Belgium· 15 yrs active
Conclusion
A bankruptcy procedure is open for NEUROGENE-RIBAI according to publications in the Belgian State Gazette. The 2022 annual accounts show equity of €730k and a net result of €129k.
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €730k |
| Net result | €129k |
| Active | 15 yrs |
| Locations | 2 |
Financial profile
53
/ 100
Mixed profile: strong on solvency, weaker on stability.
All 5 axes are computed from data Checked has read.
Health
24
Profitability
96
Solvency
100
Growth
43
Stability
0
Bankruptcy probability (12 mo)
Bankruptcy opened
A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.
Risk Assessment
50 / 100
High riskRegister: open bankruptcyThis score counts publications in the Belgian State Gazette only. The KBO register additionally records legal situation 050 for this company; it does not feed the figure above.
Components
· Open bankruptcy (+50)
Trust signals
Register: open bankruptcy
The KBO register records legal situation 050 for this company. This is today's state according to the register itself; the register carries no start date.
Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Health barometer
24
/ 100
Critical
Computed from 6 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2022 and an insolvency signal from the Belgian State Gazette. Indicative, not credit advice.
Financial overview
Annual accounts filed on 28-02-2023 with the NBB · fiscal year 2022 · volledig
€176k
-28.6%
19-22
€157k
-32.7%
19-22
€129k
-15.7%
19-22
€134k
-21.5%
19-22
€1.19M
-24.3%
19-22
€730k
+17.2%
19-22
€978k
+7.1%
19-22
€43k
+8.7%
19-22
Show 12 other metrics
€361k
-57.5%
19-22
€144k
+19.4%
19-22
€216k
-70.4%
19-22
7.78
-9.1%
19-22
7.78
-9.1%
19-22
61.3%
+54.9%
19-22
0.49
-63.8%
19-22
17.6%
-28.1%
19-22
10.8%
+11.3%
19-22
73.0%
+18.0%
19-22
88.8%
-5.8%
19-22
8.19
+101.3%
19-22
Figures by fiscal year
| Fiscal year | 2022 |
|---|---|
| Deposit | volledig |
| Revenue | €176k |
| EBITDA | €157k |
| Net profit | €129k |
| Cash flow | €134k |
| Staff costs | - |
| Income taxes | €43k |
| Dividends | - |
| Total assets | €1.19M |
| Equity | €730k |
| Debt | €361k |
| of which ≤ 1y | €144k |
| of which > 1y | €216k |
| Working capital | €978k |
| Employees (FTE) | - |
Ratios (computed)
| 2022 | |
|---|---|
| Current ratio | 7.78 |
| Quick ratio | 7.78 |
| Working capital ratio | 82.1% |
| Solvency | 61.3% |
| Debt / equity | 0.49 |
| Long-term debt ratio | 0.30 |
| Interest coverage | 8.19 |
| Gross margin | 17.1% |
| Net margin | 73.0% |
| ROA | 10.8% |
| ROE | 17.6% |
| EBITDA margin | 88.8% |
| Days sales outstanding | 1d |
| Days payable outstanding | 22d |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2022
Full annual accounts (26 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.19M |
| Fixed assets | 21/28 | €69k |
| Tangible fixed assets | 22/27 | €18k |
| Financial fixed assets | 28 | €51k |
| Current assets | 29/58 | €1.12M |
| Amounts receivable within one year | 40/41 | €270k |
| Cash & bank | 54/58 | €1k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.19M |
| Equity | 10/15 | €730k |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €137k |
| Accumulated profits (losses) | 14 | €581k |
| Provisions & deferred taxes | 16 | €100k |
| Amounts payable | 17/49 | €361k |
| Amounts payable after one year | 17 | €216k |
| Amounts payable within one year | 42/48 | €144k |
| Trade debts payable within one year | 44 | €9k |
| Income statement | ||
| Turnover | 70 | €176k |
| Gross operating margin | 9900 | €162k |
| Operating result | 9901 | €151k |
| Financial income | 75 | €39k |
| Financial charges | 65 | €19k |
| Result before taxes | 9903 | €172k |
| Income taxes | 67/77 | €43k |
| Net result for the period | 9904 | €129k |
| Result to be appropriated | 9905 | €129k |
This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan.
See plans →
Ratios computed by Checked.
Directors & mandates
| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | SOPHIE HUART CHAUSSEE DE WATERLOO 880,
1000 BRUXELLES- .
Co-Curateur : AKBAR ABDOLMOHAMMADI, AVENUE WINSTON
CHURCHILL 165, 1180 UCCLE- avimedical@yahoo.fr |
18-03-2024 → present | Belgian State Gazette |
Legal Structure
| NACE primary | - |
| Legal form | Private limited company (pre-2019)(015) |
| Incorporation | 04-10-2010 |
| Status | Active |
| Postal code | 1170 |
| First insolvency signal | 04-04-2024 |
| Latest insolvency signal | 04-04-2024 |
Establishment units
Neurogène-Ribaï
since 20102.303.346.063
Neurogène-Ribaï
since 20162.303.346.162
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21612C0002/00E002 | Brussels | 1,146 m² | 1 · 1,012 m² | 22.0 m · 6 fl. |
| 21017D0075/00F003 | Brussels | 276 m² | 1 · 119 m² | 7.0 m · 1 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2024
04-04-2024
Bankruptcy
Opening
2023
28-02-2023
NBB filing
Annual accounts filed
2022
30-04-2022
NBB filing
Annual accounts filed
2021
30-04-2021
NBB filing
Annual accounts filed
2020
03-02-2020
NBB filing
Annual accounts filed
2019
28-02-2019
NBB filing
Annual accounts filed
2018
28-02-2018
NBB filing
Annual accounts filed
2016
04-07-2016
NBB filing
Annual accounts filed
2015
28-09-2015
NBB filing
Annual accounts filed
2014
04-06-2014
NBB filing
Annual accounts filed
2013
02-07-2013
NBB filing
Annual accounts filed
Lifecycle & Insolvency Signals
04-04-2024
Bankruptcy
Opening
Time machine, BS events + macro context
Macro context
2020-Q2/Q3 COVID lockdown
2022 energy crisis
2023-2024 ECB rate hikes
Legend
Bankruptcy
Interim / reorg
KBO event
Belgian State Gazette reading coverage
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Names & trade names
| Legal nameFR | NEUROGENE-RIBAI |
Registered office
Louis Ernottestraat 58B
1170 Watermaal-Bosvoorde, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.